Hevolution Foundation convenes leading experts at the Global Healthspan Summit to discuss mobilizing $2.1 billion in funding, repurposing GLP-1 therapies, leveraging a 1.5 million-participant health database and fast-track regulations to accelerate healthspan-extension innovations worldwide.

Key points

• Hevolution Foundation launches a $2.1 billion challenge fund to incentivize healthspan research and entrepreneurship.
• Researchers highlight repurposing GLP-1 agonists for longevity, leveraging known safety profiles for rapid clinical testing.
• UK’s Our Future Health program provides a 1.5 million-participant blood sample database to power preventive and longevity research.

Why it matters: This global convergence of funding, datasets, regulatory innovation and translational strategies paves scalable pathways to extend healthy human lifespan and reduce age-related disease burdens.